The interaction of miR-181a-5p and sirtuin 1 regulated human bone marrow mesenchymal stem cells differentiation and apoptosis

References

• Aggarwal L, Masuda C. Osteoporosis: a quick update. J Fam Pract. 2018;67(2):59–65.
   PubMed Web of Science ®Google Scholar
• Kemp JP, Morris JA,  Medina-Gomez C, et al. Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis. Nat Genet. 2017;49(10):1468–1475.
   PubMed Web of Science ®Google Scholar
• Lian JB, Stein GS, van Wijnen AJ, et al. MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol. 2012;8(4):212–227.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–147.
   PubMed Web of Science ®Google Scholar
• Porada CD, Almeida-Porada G. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev. 2010;62(12):1156–1166.
   PubMed Web of Science ®Google Scholar
• Gao Y-F, et al. miR-142 suppresses proliferation and induces apoptosis of osteosarcoma cells by upregulating Rb.. Oncol Lett. 2018;16(1):733–740.
   PubMed Web of Science ®Google Scholar
• Agostini M, Knight RA. miR-34: from bench to bedside. Oncotarget. 2014;5(4):872–881.
   PubMedGoogle Scholar
• Gomez IG, MacKenna DA,  Johnson BG, et al. Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways. J Clin Invest. 2015;125(1):141–156.
   PubMed Web of Science ®Google Scholar
• Kaboli PJ, Rahmat A,  Ismail P, et al. MicroRNA-based therapy and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment. Pharmacol Res. 2015;97:104–121.
   PubMed Web of Science ®Google Scholar
• Matsui M, Corey DR. Non-coding RNAs as drug targets. Nat Rev Drug Discov. 2017;16(3):167–179.
   PubMed Web of Science ®Google Scholar
• Thakral S, Ghoshal K. miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir. Curr Gene Ther. 2015;15(2):142–150.
   PubMed Web of Science ®Google Scholar
• Bellavia D, De Luca A,  Carina V, et al. Deregulated miRNAs in bone health: epigenetic roles in osteoporosis. Bone. 2019;122:52–75.
   PubMed Web of Science ®Google Scholar
• Inoue K, Deng Z,  Chen Y, et al. Bone protection by inhibition of microRNA-182. Nat Commun. 2018;9(1):4108.
   PubMedGoogle Scholar
• Li C-J, Cheng P,  Liang MK, et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J Clin Invest. 2015;125(4):1509–1522.
   PubMed Web of Science ®Google Scholar
• Meng J, Zhang D, Pan N, et al. Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis. PeerJ. 2015;3(p): e971-e971. doi:10.7717/peerj.971.
   Google Scholar
• Ellur G,  Zhang D, Pan N, et al. Maternal high protein-diet programs impairment of offspring’s bone mass through miR-24-1-5p mediated targeting of SMAD5 in osteoblasts. Cell Mol Life Sci. 2021;78(4):1729–1744.
   PubMed Web of Science ®Google Scholar
• Ji H, Wang H, Ji Q, et al. Differential expression profile of microRNA in yak skeletal muscle and adipose tissue during development. Genes Genomics. 2020;42(11):1347–1359.
   PubMed Web of Science ®Google Scholar
• Xia S, Tian H,  Fan L, et al. Peripheral Blood miR-181-5p Serves as a Marker for Screening Patients with Osteoarthritis by Targeting TNFα. Clin Lab. 2017;63(11):1819–1825.
   PubMed Web of Science ®Google Scholar
• Stolzing A, Jones E,  McGonagle D, et al. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev. 2008;129(3):163–173.
   PubMed Web of Science ®Google Scholar
• Bhushan R, Grünhagen J,  Becker J, et al. miR-181a promotes osteoblastic differentiation through repression of TGF-β signaling molecules. Int J Biochem Cell Biol. 2013;45(3):696–705.
   PubMed Web of Science ®Google Scholar
• Zhang W,  Wu Y,  Shiozaki Y, et al. miRNA-133a-5p Inhibits the Expression of Osteoblast Differentiation-Associated Markers by Targeting the 3ʹ UTR of RUNX2. DNA Cell Biol. 2018;37(3):199–209.
   PubMed Web of Science ®Google Scholar
• Riaz F, et al. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs througChen Q,  Lu K, h PTEN/PI3K/AKT pathway. J Cell Mol Med. 2021. DOI:10.1111/jcmm.16376.
   PubMed Web of Science ®Google Scholar
• Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597–610.
   PubMed Web of Science ®Google Scholar
• Sun DG, Xin BC,  Wu D, et al. miR-140-5p-mediated regulation of the proliferation and differentiation of human dental pulp stem cells occurs through the lipopolysaccharide/toll-like receptor 4 signaling pathway. Eur J Oral Sci. 2017;125(6):419–425. .
   PubMed Web of Science ®Google Scholar
• Fan L, Wang J, Ma C. miR125a attenuates BMSCs apoptosis via the MAPK-ERK pathways in the setting of craniofacial defect reconstruction. J Cell Physiol. 2020;235(3):2857–2865.
   PubMed Web of Science ®Google Scholar
• Hu J, et al. BMSC paracrine activity attenuates interleukin-1β-induced inflammation and apoptosis in rat AF cells via inhibiting relative NF-κB signaling and the mitochondrial pathway.. Am J Transl Res. 2017;9(1):79–89.
   PubMed Web of Science ®Google Scholar
• Li X,  Zhan J,  Hou Y, et al. Coenzyme Q10 Regulation of Apoptosis and Oxidative Stress in H(2)O(2) Induced BMSC Death by Modulating the Nrf-2/NQO-1 Signaling Pathway and Its Application in a Model of Spinal Cord Injury. Oxid Med Cell Longev. 2019;2019:6493081.
   PubMed Web of Science ®Google Scholar
• Zhao S, Liu Y, Pu Z. Bone marrow mesenchymal stem cell-derived exosomes attenuate D-GaIN/LPS-induced hepatocyte apoptosis by activating autophagy in vitro. Drug Des Devel Ther. 2019;13:2887–2897.
   PubMed Web of Science ®Google Scholar
• Wang X,  Zhang Y,  Choukroun J, et al. Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets. 2018;29(1):48–55.
   PubMed Web of Science ®Google Scholar
• Chauhan S, Sharma A,  Upadhyay NK, et al. In-vitro osteoblast proliferation and in-vivo anti-osteoporotic activity of Bombax ceiba with quantification of Lupeol, gallic acid and β-sitosterol by HPTLC and HPLC. BMC Complement Altern Med. 2018;18(1):233.
   PubMedGoogle Scholar
• Bruderer M, Richards RG，Alini M, et al. Role and regulation of RUNX2 in osteogenesis. Eur Cell Mater. 2014;28:269–286.
   PubMed Web of Science ®Google Scholar
• Galindo M, Pratap J,  Young DW, et al. The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts. J Biol Chem. 2005;280(21):20274–20285.
   PubMed Web of Science ®Google Scholar
• Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature. 2009;460(7255):587–591.
   PubMed Web of Science ®Google Scholar
• Yoon DS, Choi Y,  Jang Y, et al. SIRT1 directly regulates SOX2 to maintain self-renewal and multipotency in bone marrow-derived mesenchymal stem cells. Stem Cells. 2014;32(12):3219–3231.
   PubMed Web of Science ®Google Scholar
• Zainabadi K, Liu CJ,  Caldwell ALM, et al. SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis. PLoS One. 2017;12(9):e0185236.
   PubMed Web of Science ®Google Scholar
• Deng S, Dai G,  Chen S, et al. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3β signaling pathway. Biomed Pharmacother. 2019;110:602–608.
   PubMed Web of Science ®Google Scholar
• Ye C,  Zhang W,  Hang K, et al. Extracellular IL-37 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via activation of the PI3K/AKT signaling pathway. Cell Death Dis. 2019;10(10):753.
   PubMedGoogle Scholar